Major Drug Interactions

Why This Matters

Drug interactions represent one of the most clinically significant—and most testable—concepts in pharmacology. You're not just being asked to memorize which drugs don't play well together; you're being tested on the underlying mechanisms that explain why these interactions occur. Understanding these mechanisms allows you to predict interactions you've never seen before, which is exactly the kind of applied thinking that separates strong exam performance from rote memorization.

The interactions in this guide demonstrate core pharmacological principles: enzyme inhibition, additive effects, altered renal clearance, and receptor-level synergism. Each example illustrates how drugs can modify absorption, distribution, metabolism, or excretion (ADME) of other compounds—or how they can amplify effects at the same physiological target. Don't just memorize the pairs; know what mechanism each interaction demonstrates and what clinical consequence results.

---

Enzyme Inhibition Interactions

Many dangerous drug interactions occur when one drug inhibits the cytochrome P450 enzymes responsible for metabolizing another. When metabolism slows, drug levels rise—often into toxic ranges.

Statins and Grapefruit Juice

• CYP3A4 inhibition is the mechanism—grapefruit juice blocks the enzyme that normally breaks down certain statins
• Elevated plasma statin levels increase the risk of myopathy, a potentially serious muscle breakdown condition
• Patient counseling is essential; advise avoidance of grapefruit products during statin therapy

Theophylline and Ciprofloxacin

• CYP1A2 inhibition by ciprofloxacin slows theophylline metabolism, causing drug accumulation
• Theophylline toxicity symptoms include insomnia, tremors, seizures, and cardiac palpitations
• Therapeutic drug monitoring becomes critical when fluoroquinolones are co-prescribed with theophylline

Digoxin and Amiodarone

• P-glycoprotein inhibition by amiodarone reduces digoxin clearance, raising serum concentrations by 70-100%
• Digoxin toxicity presents with nausea, visual disturbances (yellow-green halos), and arrhythmias
• Dose reduction of digoxin by approximately 50% is standard practice when adding amiodarone

---

Additive Pharmacodynamic Effects

Some interactions occur not through altered drug levels but through combined effects on the same physiological system. When two drugs push in the same direction, the result can be dangerously amplified.

Warfarin and NSAIDs

• Dual bleeding risk—NSAIDs inhibit platelet function while warfarin blocks clotting factor synthesis
• GI mucosal damage from NSAIDs compounds the hemorrhage risk in anticoagulated patients
• INR monitoring must increase in frequency if NSAID use cannot be avoided

Benzodiazepines and Alcohol

• CNS depression synergy—both enhance GABAergic inhibition, causing additive sedation
• Respiratory depression is the life-threatening consequence, especially at higher doses
• Patient education about avoiding alcohol is a critical counseling point for benzodiazepine prescriptions

---

Receptor-Level Synergism

When drugs act on the same receptor system or neurotransmitter pathway, their combined effect can trigger dangerous physiological responses that neither drug would cause alone.

MAOIs and SSRIs

• Serotonin syndrome results from excessive serotonergic activity—a potentially fatal emergency
• Clinical presentation includes hyperthermia, agitation, tremor, hyperreflexia, and autonomic instability
• Washout period of 2-5 weeks is mandatory when switching between these drug classes

---

Altered Renal Clearance

The kidney eliminates many drugs, and interactions that affect renal handling can dramatically alter drug concentrations. Drugs that compete for tubular secretion or alter renal blood flow are common culprits.

Methotrexate and NSAIDs

• Reduced renal clearance of methotrexate occurs because NSAIDs compete for tubular secretion
• Methotrexate toxicity causes bone marrow suppression, hepatotoxicity, and mucositis
• High-dose methotrexate protocols absolutely require NSAID avoidance and level monitoring

Lithium and Diuretics

• Sodium depletion from diuretics triggers compensatory lithium reabsorption in the proximal tubule
• Lithium toxicity symptoms progress from tremor and GI upset to confusion, seizures, and renal failure
• Thiazide diuretics are particularly problematic; loop diuretics pose somewhat less risk

---

Electrolyte Disturbance Interactions

Some interactions create dangerous imbalances in serum electrolytes, with cardiac consequences that can be immediately life-threatening.

ACE Inhibitors and Potassium Supplements

• Hyperkalemia risk increases because ACE inhibitors reduce aldosterone, decreasing potassium excretion
• Cardiac arrhythmias including fatal ventricular fibrillation can result from elevated $K^+$ levels
• Serum potassium monitoring is essential, especially in patients with renal impairment

---

Reduced Drug Efficacy

Not all interactions increase toxicity—some reduce therapeutic effect, leading to treatment failure with serious consequences.

Oral Contraceptives and Certain Antibiotics

• Enzyme induction by rifampin (and possibly other antibiotics) accelerates estrogen metabolism
• Contraceptive failure can result in unintended pregnancy if backup methods aren't used
• Patient counseling should address backup contraception during and after antibiotic courses

---

Quick Reference Table

---

Self-Check Questions

1. Which two interactions in this guide involve NSAIDs, and how do their mechanisms differ?

2. A patient on digoxin is started on amiodarone. What dose adjustment is typically required, and why?

3. Compare the lithium + diuretics interaction with the methotrexate + NSAIDs interaction. Both involve renal mechanisms—what's the key difference in how renal handling is altered?

4. Why does serotonin syndrome require a washout period when switching between MAOIs and SSRIs, while most other interactions can be managed with monitoring alone?

5. An FRQ asks you to explain why grapefruit juice is dangerous with some statins but not others. What pharmacokinetic principle would you use to answer this? (Hint: not all statins are metabolized by the same enzyme.)